Hie‐Won Hann

2.4k citations
33 papers · 1.9k indexed · 1 hit paper · h-index 15
Topics
Hepatitis B Virus Studies (27 papers)Hepatitis C virus research (26 papers)Liver Disease Diagnosis and Treatment (21 papers)
Journals
SHILAP Revista de lepidopterologíaGastroenterologyPLoS ONE
Partner nations
United StatesChinaCanada

In The Last Decade

Hie‐Won Hann

30 papers receiving 1.9k citations

Hit Papers

Histological outcome during long-term lamivudine therapy20032026201020182003100200300400500

Peers

Hie‐Won Hann
Comparison fields: 5 of 76
  • Epidemiology 1.7k
  • Hepatology 1.7k
  • Infectious Diseases 258
  • Molecular Biology 58
  • Oncology 55
Replace Lydia Tang with:
Lydia Tang United States
Corinne Castelnau France
Henry Lik‐Yuen Chan Hong Kong
Naoky Tsai United States
Arnolfo Petruzziello Italy
Isla Humphreys United Kingdom
A DIBISCEGLIE United States
Kathryn Razavi‐Shearer United States
Eduardo B. Martins United States
Milan J. Sonneveld Netherlands
Hie‐Won Hann relative to Lydia Tang United States Lydia Tang's profile →
Citations per field
00.5×1.5×2.3×
Lydia Tang · 1×
Citations per year

Countries citing papers authored by Hie‐Won Hann

Since Specialization
Citations

This map shows the geographic impact of Hie‐Won Hann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hie‐Won Hann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hie‐Won Hann more than expected).

Fields of papers citing papers by Hie‐Won Hann

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hie‐Won Hann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hie‐Won Hann. The network helps show where Hie‐Won Hann may publish in the future.

Co-authorship network of co-authors of Hie‐Won Hann

This figure shows the co-authorship network connecting the top 25 collaborators of Hie‐Won Hann. A scholar is included among the top collaborators of Hie‐Won Hann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hie‐Won Hann. Hie‐Won Hann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 3
2 12
3 1
4 0
5 40
6 26
7 4
8 30
9
Advances in the management of hepatitis B virus infection.
1
10 15
11 21
12 47
13 69
14 21
15 146
16 19
17
Adefovir dipivoxil alone or in combination with lamivudine in patients with lamivudine-resistant chronic hepatitis B 1 1The Adefovir Dipivoxil International 461 Study Group includes the following: N. Afdhal (Beth Israel Deaconess Medical Center, Boston, MA); P. Angus (Austin and Repatriation Medical Centre, Melbourne, Australia); Y. Benhamou (Hopital La Pitie Salpetriere, Paris, France); M. Bourliere (Hopital Saint Joseph, Marseille, France); P. Buggisch (Universitaetsklinikum Eppendorf, Department of Medicine, Hamburg, Germany); P. Couzigou (Hopital Haut Leveque, Pessac, France); P. Ducrotte and G. Riachi (Hopital Charles Nicolle, Rouen, France); E. Jenny Heathcote (Toronto Western Hospital, Toronto, Ontario, Canada); H. W. Hann (Jefferson Medical College, Philadelphia, PA); I. Jacobson (New York Presbyterian Hospital, New York, NY); K. Kowdley (University of Washington Hepatology Center, Seattle, WA); P. Marcellin (Hopital Beaujon, Clichy, France); P. Martin (Cedars-Sinai Medical Center, Los Angeles, CA); J. M. Metreau (Centre Hospitalier Universitaire Henri Mondor, Creteil, France); M. G. Peters (University of California, San Francisco, San Francisco, CA); R. Rubin (Piedmont Hospital, Atlanta, GA); S. Sacks (Viridae Clinical Sciences, Inc., Vancouver, Canada); H. Thomas (St. Mary’s Hospital, London, England); C. Trepo (Hopital Hôtel Dieu, Lyon, France); D. Vetter (Hopital Civil, Strasbourg, France); C. L. Brosgart, R. Ebrahimi, J. Fry, C. Gibbs, K. Kleber, J. Rooney, M. Sullivan, P. Vig, C. Westland, M. Wulfsohn, and S. Xiong (Gilead Sciences, Inc., Foster City, CA); D. F. Gray (GlaxoSmithKline, Greenford, Middlesex, England); R. Schilling and V. Ferry (Parexel International, Waltham, MA); and D. Hunt (Covance Laboratories, Princeton, NJ).
440
18
Histological outcome during long-term lamivudine therapybreakdown →
583
19 1
20 22

About Hie‐Won Hann

Hie‐Won Hann is a scholar working on Hepatology, Epidemiology and Infectious Diseases, having authored 33 papers that have together received 1.9k indexed citations. Recurring topics across this work include Hepatitis B Virus Studies (27 papers), Hepatitis C virus research (26 papers) and Liver Disease Diagnosis and Treatment (21 papers). The work is most often cited by research in Hepatology (1.7k citations), Epidemiology (1.7k citations) and Infectious Diseases (258 citations). Hie‐Won Hann has collaborated with scholars based in United States, China and Canada. Frequent co-authors include DF Gray, Mary Woessner, Jules L. Dienstag, Eugene R. Schiff, Stephen D. Gardner, Robert Goldin, Sally L. Stephenson, E. Jenny Heathcote, Nancy Leung and Myron J. Tong. Their work appears in journals such as SHILAP Revista de lepidopterología, Gastroenterology and PLoS ONE.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026